News | Yale Ventures

News

News from Yale's innovation and entrepreneurship community

Search (News)

Search (News)

News Type

Target Audience

Nuritas™ Announces North American Headquarters, CEO to Relocate to US

Startups & Spinouts

05/17/2022
Osmol Therapeutics Announces Closing of Series A-1 Funding to Advance the Clinical Development of the First Therapy to Prevent Chemotherapy-induced Neuropathy

Startups & Spinouts

04/10/2022
Qx Therapeutics Inc. has received FDA authorization of “Study May Proceed” with a Phase 2 Clinical Trial of QXT-101 for the prevention and treatment of PGD in lung transplant recipients.”

Startups & Spinouts

02/10/2022
Xanadu Bio Obtains Licenses and Options to Novel Platform Technologies from Yale University

Startups & Spinouts

02/08/2022
Leading (Yale) Bioscience Entrepreneurs Sign Leases at New 113,000 SF Elm City Bioscience Center in New Haven

Startups & Spinouts

02/01/2022
Center for Biomedical Innovation and Technology (CBIT)

Spring Health Notches A $190 Million Series C At A $2 Billion Valuation, Making CEO April Koh The Youngest Woman To Run A Unicorn

Startups & Spinouts

09/16/2021
Center for Biomedical Innovation and Technology (CBIT)

RxAll grabs $3.15M to scale its drug checking and counterfeiting tech across Africa

Startups & Spinouts

07/21/2021
Blavatnik-Funded Technology from Yale Secures $40M Investment

Startups & Spinouts

07/12/2021
amplifyHERscience

Osmol Therapeutics Initiates IND Enabling Studies to Develop First Therapy for Prevention of Chemotherapy-Induced Peripheral Neuropathy

Startups & Spinouts

06/01/2021
Alexion founder Squinto helms OrbiMed-backed startup with some Yale gene therapy tech

Startups & Spinouts

05/18/2021